Short Interest in Carmell Co. (NASDAQ:CTCX) Increases By 64.3%

Carmell Co. (NASDAQ:CTCXGet Free Report) was the target of a significant growth in short interest in April. As of April 15th, there was short interest totalling 23,500 shares, a growth of 64.3% from the March 31st total of 14,300 shares. Approximately 0.2% of the shares of the stock are sold short. Based on an average daily trading volume, of 6,200 shares, the days-to-cover ratio is presently 3.8 days.

Carmell Stock Performance

Carmell stock opened at $2.09 on Friday. Carmell has a 12 month low of $1.70 and a 12 month high of $13.31. The business has a 50 day simple moving average of $2.64 and a 200-day simple moving average of $2.94.

Institutional Trading of Carmell

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Meteora Capital LLC purchased a new stake in shares of Carmell in the third quarter valued at approximately $6,416,000. Carnegie Mellon University purchased a new stake in shares of Carmell in the third quarter valued at approximately $371,000. Linden Advisors LP purchased a new stake in shares of Carmell in the third quarter valued at approximately $270,000. Cookson Peirce & Co. Inc. purchased a new stake in shares of Carmell during the third quarter worth approximately $54,000. Finally, Hubbell Strickland Wealth Management LLC purchased a new stake in shares of Carmell during the first quarter worth approximately $32,000. 24.22% of the stock is currently owned by hedge funds and other institutional investors.

Carmell Company Profile

(Get Free Report)

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of a potent cocktail of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.

Featured Stories

Receive News & Ratings for Carmell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carmell and related companies with MarketBeat.com's FREE daily email newsletter.